Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors

Completed · Phase 1

Conditions studied: Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific

In brief

Phase I trial to study the effectiveness of tributyrin in treating patients with refractory stage IV prostate cancer or other solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Key facts

Study ID

NCT00002677

Run by

University of Maryland, Baltimore

People needed

24

Starts

1995-08-01

Expected to finish

2003-03-01

Last updated by the study team

2019-11-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Marlene & Stewart Greenebaum Cancer Center, University of Maryland — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.